多国CT辐射剂量登记:5年累积有效剂量分析
生存分析校正数据删失后发现,高累积剂量并不少见,尤其在体型较大患者中,重复成像是主要驱动因素。
要点
- 体型较大患者CT累积剂量明显更高,阅片时可关注其既往检查频次与剂量负担。
- 重复成像是高累积剂量的主要驱动因素,报告时可提示避免不必要复查。
- 英格兰患者超标比例低于平均水平,提示不同地区CT使用与剂量控制存在差异。
核心结论
- 高累积剂量并非罕见,尤其在体型较大患者中比例明显升高。
- 重复成像是导致高累积剂量的主要驱动因素。
- 校正数据删失后,高累积剂量患者比例较既往报告明显更高。
研究设计与样本
- 采用生存分析校正数据删失,估算1年和5年累积有效剂量超过50 mSv与100 mSv的患者比例。
- 分析相关驱动因素包括患者体型、检查类型和国家。
诊断标准与关键数值
- 5年内累积50 mSv:平均体型成人估计为13%,平均体型儿童为5%;大体型成人为56%,大体型儿童为27%。
- 5年内累积100 mSv:平均体型成人估计为4%,平均体型儿童为1%;大体型成人为31%,大体型儿童为13%。
- 英格兰患者超过上述剂量水平的比例较平均值低1.7至5倍。
临床应用与阅片要点
- 影像报告系统可自动关联既往CT检查次数,对重复检查频繁者提示累积剂量风险。
- 阅片时如需建议复查,应综合权衡诊断获益与患者年龄、体型及既往CT累积剂量。
- 大体型患者CT剂量更高,优化扫描参数时需关注体型适配方案。
局限性
- 回顾性研究,来自多国登记数据,存在地区间设备、扫描方案和记录完整性的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To understand the percentage of patients who exceed a cumulative effective dose of 50 or 100 mSv within 1-5 years of first CT scan, while accounting for data censoring (i.e. considering patients who are no longer being followed in the study and whose unobserved exams may influence the estimates)-a major limitation of prior reports.
METHODS: A retrospective, multi-national study of 5.6 million CT exams in 2.8 million patients from 161 hospitals between 2010 and 2021. We quantified the percentage of exams with effective doses >50 and >100 mSv, and using survival analysis, projected the percentage of patients with cumulative effective doses above these levels at 1 and 5 years and identified relevant drivers (eg, patient size, exam type, country).
RESULTS: A total of 189 981 (3.4%) examinations were >50 mSv and 14 906 (0.3%) >100 mSv, varying by patient age, size, and exam type. Overall, 13% of average-sized adults and 5% of average-sized children were estimated to accumulate 50 mSv over 5 years (56% and 27% of large-sized adults and children, respectively), whereas 4% of average-sized adults and 1% of average-sized children were estimated to accumulate 100 mSv over 5 years (31% and 13% of large-sized adults and children, respectively). England had a 1.7- to 5-times lower than average percentage of patients exceeding levels.
CONCLUSIONS: High cumulative doses were not rare, particularly high in larger patients, and repeat imaging was a strong driver of these exposures.
ADVANCES IN KNOWLEDGE: When accounting for data censoring, a considerably larger share of patients accumulated a high effective dose from CT than has been previously reported, exceeding radiation dose ranges associated with radiation-induced cancer.
引用
- Malekhedayat, Wang, Chu, et al. Cumulative effective dose among 5.6 million CT exams in a multinational radiation dose registry. Br J Radiol. 2026. PMID: 42316842. doi:10.1093/bjr/tqag115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。